ReviewCNS & neurological disorders drug targets2024

A Comprehensive Review of the Docking Studies of Chalcone for the Development of Selective MAO-B Inhibitors.

Athulya Krishna et al.PubMed ↗Publisher ↗

No numbers read from the abstract.